On Friday, TherapeuticsMD Inc (NASDAQ: TXMD) appear FDA approval of the first-ever patient-controlled long-acting capricious l bearing ascendancy system.
The FDA approved TherapeuticsMD’s ANNOVERA decree bearing ascendancy ring, which is amid into the and removed by the user herself at her acumen and prevents ovulation for an absolute year.
Why It’s Important
The new bearing ascendancy is the aboriginal of its affectionate and is acceptable to be classified as a “new actinic entity,” which would potentially grant TherapeuticsMD bristles years of apparent exclusivity.
“The U.S. contraceptive bazaar is alive against long-acting solutions and we accept ANNOVERA represents an agitative new aspirant for women and healthcare providers by accouterment the aboriginal woman-controlled, procedure-free, long-acting, capricious bearing ascendancy artefact putting the woman in ascendancy of both her abundance and menstruation,” said Dr. Brian Bernick, Co-Founder of TherapeuticsMD.
ANNOVERA is a abeyant another to both circadian articulate contraceptives and long-acting implants that crave invasive procedures. After actuality apoplectic for about 90 minutes, TherapeuticsMD banal bankrupt up about 1 percent Friday afterward the news, but investors will be watching to see if women adopt the new contraceptive adjustment to the accepted methods available. According to Statista, the all-around contraceptives bazaar will abound to a $23.1 billion industry by 2020.
The Circadian Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss
FDA Decision Sends Pain Therapeutics Reeling
See added from Benzinga
© 2018 Benzinga.com. Benzinga does not accommodate advance advice. All rights reserved.
Attending Forms Of Birth Control Can Be A Disaster If You Forget These Five Rules | Forms Of Birth Control – forms of birth control
| Welcome to help our blog site, in this particular time I’ll show you in relation to forms of birth control